Fig. 3. TUG1 positively regulates KDM2A by binding to miR-421 in HCT116 cells.
A Determination of miR-421 expression in the CRC and adjacent normal tissues (n = 20) by RT-qPCR. B Determination of miR-421 expression in HCT116 and SW480 cells transfected with si-TUG1-1 by RT-qPCR. C The binding of TUG1 to miR-421 in HCT116 cells verified by dual-luciferase reporter assay. D The binding of TUG1 to miR-421 in HCT116 cells tested by RIP assay in combination with qPCR. E The binding of TUG1 to miR-421 in HCT116 cells tested using RNA pull-down. F Determination of KDM2A expression in the CRC and adjacent normal tissues (n = 20) by RT-qPCR. G The binding between miR-421 and KDM2A in HCT116 cells identified using dual-luciferase reporter assay. H The binding of miR-421 to KDM2A in HCT116 cells tested by RIP assay in combination with qPCR. I The binding of miR-421 to KDM2A in HCT116 cells tested using RNA pull-down. J Determination of TUG1, miR-421 and KDM2A expression in HCT116 cells transfected with miR-421 mimic by RT-qPCR. K Measurement of KDM2A protein level in HCT116 cells transfected with miR-421 mimic by western blot assay. L Determination of TUG1, miR-421 and KDM2A expression in HCT116 cells transfected with si-TUG1-1 or combined with miR-421 inhibitor by RT-qPCR. M Measurement of KDM2A protein level in HCT116 cells transfected with si-TUG1-1 or combined with miR-421 inhibitor by western blot assay. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001, compared with adjacent normal tissues, HCT116 cells transfected with si-NC, mimic NC or si-NC + inhibitor NC, or HCT116 cells incubated with IgG or Bio-NC. #p < 0.05, ##p < 0.01, and ####p < 0.0001, compared with HCT116 cells transfected with si-TUG1-1 + inhibitor NC. The measurement data are expressed as mean ± standard deviation. The experiments were repeated three times independently. Comparison between two groups was conducted by unpaired t-test. Multi-group comparison was conducted by one-way ANOVA with Tukey’s post hoc test.